High levels of IL-8 and MCP-1 in cerebrospinal fluid of COVID-19 patients with cerebrovascular disease

6Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

The coronavirus family has tropism for the Central Nervous System (CNS), however, there is no solid evidence demonstrating that the neurological effects of COVID-19 result from direct viral infection or systemic inflammation. The goals of this study were to examine the cytokine profile and the presence of SARS-CoV-2 messenger ribonucleic acid (mRNA) in cerebrospinal fluids (CSF) from two patients with cerebrovascular disease and COVID-19. Although the SARS-CoV-2 mRNA was not detected in CSF of both patients, we found abnormally high levels of numerous proinflammatory cytokines and chemokines, especially IL-8 and MCP-1. Since these chemokines mediate activation and recruitment of neutrophils, monocytes, and macrophages, it is feasible that cerebrovascular disease related-neuroinflammation found in both patients results from an exacerbated inflammatory response instead of SARS-CoV-2 direct invasion to CNS. These results suggest that neuroinflammation plays a key role in cerebrovascular disease and COVID-19.

Cite

CITATION STYLE

APA

Guartazaca-Guerrero, S., Rodríguez-Morales, J., Rizo-Téllez, S. A., Solleiro-Villavicencio, H., Hernández-Valencia, A. F., Carrillo-Ruiz, J. D., … Méndez-García, L. A. (2021). High levels of IL-8 and MCP-1 in cerebrospinal fluid of COVID-19 patients with cerebrovascular disease. Experimental Neurobiology, 30(3), 256–261. https://doi.org/10.5607/en21009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free